I note also that there have been plenty of Aussie companies that focused on excellent R&D at the expense of commercialisation that are no longer with us.
PolyNovo has escaped that fate and in the years to come will have, no doubt, a broad portfolio of NovoSorb products just because in its early days it focused on bringing in the dollars.
- Forums
- ASX - By Stock
- Medtronic has entered the market for resorbable mesh Ventral Hernia Repair
I note also that there have been plenty of Aussie companies that...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.51 |
Change
-0.030(1.18%) |
Mkt cap ! $1.746B |
Open | High | Low | Value | Volume |
$2.55 | $2.56 | $2.50 | $1.366M | 539.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
23 | 46657 | $2.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.52 | 28809 | 26 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 39403 | 2.500 |
15 | 42234 | 2.490 |
11 | 81424 | 2.480 |
10 | 196587 | 2.470 |
3 | 4875 | 2.460 |
Price($) | Vol. | No. |
---|---|---|
2.510 | 14900 | 24 |
2.520 | 41083 | 22 |
2.530 | 46438 | 15 |
2.540 | 83578 | 16 |
2.550 | 52229 | 13 |
Last trade - 14.00pm 13/08/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online